UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management

Nutrition, metabolism, and cardiovascular diseases, 2010-02, Vol.20 (2), p.140-146

2010

Volltextzugriff (PDF)

High-density lipoprotein, vascular risk, cancer and infection: a case of quantity and quality?

Current medicinal chemistry, 2014-01, Vol.21 (25), p.2917-2926

2014

Volltextzugriff (PDF)

Corrigendum: The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update

Current pharmaceutical design, 2015-08, Vol.21 (24), p.3565-3565

2015

Volltextzugriff (PDF)

Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors

Nutrition, metabolism, and cardiovascular diseases, 2011-03, Vol.21 (3), p.213-221

2011

Volltextzugriff (PDF)

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

Atherosclerosis, 2007-08, Vol.193 (2), p.428-437

2007

Volltextzugriff (PDF)

Implementation of strategy for the management of overt dyslipidemia: The IMPROVE-dyslipidemia study

International journal of cardiology, 2009-05, Vol.134 (3), p.322-329, Article 322

2009

Volltextzugriff (PDF)

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): A prospective-randomized study in middle aged men and women

Atherosclerosis, 2014-03, Vol.233 (1), p.327-327

2014

Volltextzugriff (PDF)

Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: A systematic review and meta-analysis of randomized-controlled trials

Atherosclerosis, 2020-12, Vol.315, p.e41-e41

2020

Volltextzugriff (PDF)

Effect of high and low dose of rosuvastatin on fatty liver disease and adipokines in patients with nonalcoholic fatty liver disease

Atherosclerosis, 2020-12, Vol.315, p.e98-e99

2020

Volltextzugriff (PDF)

Cardiovascular benefits of bariatric surgery in morbidly obese patients

Obesity reviews, 2011-07, Vol.12 (7), p.515-524

2011

Volltextzugriff (PDF)

Coexistence of cardiovascular risk factors in patients with familial hypercholesterolemia: Data from the HELLAS-FH registry

Atherosclerosis, 2020-12, Vol.315, p.e211-e211

2020

Volltextzugriff (PDF)

Clinical characteristics of patients with familial hypercholesterolemia: Data from the HELLAS-FH registry

Atherosclerosis, 2020-12, Vol.315, p.e210-e211

2020

Volltextzugriff (PDF)

Latest European guidelines for dyslipidemias in the setting of familial hypercholesterolemia: Data from the hellas-fh registry

Atherosclerosis, 2020-12, Vol.315, p.e41-e41

2020

Volltextzugriff (PDF)

Cholesterol levels of high-density lipoprotein (HDL-C), APOB/APOA1 ratio and cardiovascular risk in patients with familial hypercholesterolemia (FH): Data from the HELLAS-FH registry

Atherosclerosis, 2020-12, Vol.315, p.e39-e40

2020

Volltextzugriff (PDF)

Vitamin D deficiency, statin-related myopathy and other links with vascular risk

Current medical research and opinion, 2011-09, Vol.27 (9), p.1691-1692

2011

Volltextzugriff (PDF)

Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease

Dermatology (Basel), 2007-08, Vol.215 (2), p.164-165

2007

Volltextzugriff (PDF)

Inflammatory markers and the metabolic syndrome

Atherosclerosis, 2005-11, Vol.183 (1), p.187-188

2005

Volltextzugriff (PDF)

Undertreatment of dyslipidaemia in Greece

Atherosclerosis, 2004-11, Vol.177 (1), p.215-216

2004

Volltextzugriff (PDF)

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A 2 in obese patients with metabolic syndrome

Atherosclerosis, 2007, Vol.193 (2), p.428-437

2007

Volltextzugriff (PDF)

Statin treatment may be beneficial to both the kidneys and the heart

Peritoneal dialysis international, 2007-03, Vol.27 (2), p.215-216

2007

Volltextzugriff (PDF)

Fenofibrate and Iosartan

Annals of the rheumatic diseases, 2004-04, Vol.63 (4), p.469

2004

Volltextzugriff (PDF)

The natural history of recently diagnosed autonomic neuropathy over a period of 2 years

Diabetes research and clinical practice, 1998-10, Vol.42 (1), p.55-63

1998

Volltextzugriff (PDF)

EFFECTIVENESS OF EZETIMIBE ALONE OR IN COMBINATION WITH TWICE A WEEK ATORVASTATIN (10 MG) FOR STATIN INTOLERANT HIGH-RISK PATIENTS

Atherosclerosis. Supplements, 2008-05, Vol.9 (1), p.188-188

2008

Volltextzugriff (PDF)

PO21-669 STATINS ON RENAL FUNCTION AND SERUM-URIC ACID AND THEIR RELATION TO VASCULAR EVENTS IN CORONARY HEART DISEASE AND METABOLIC SYNDROME

Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.180-180

2007

Volltextzugriff (PDF)

PO20-609 ASSOCIATION OF DRINKING PATTERN WITH THE PREVALENCE OF METABOLIC SYNDROME, DIABETES, CORONARY HEART DISEASE, STROKE AND PERIPHERAL ARTERIAL DISEASE

Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.165-166

2007

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(12)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Female
(6)
Male
(6)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular
(5)
Cardiovascular System & Cardiology
(5)
Metabolic Syndrome
(5)
Cardiovascular Diseases - Etiology
(4)
Endocrinology & Metabolism
(4)
Middle Aged
(4)
Risk Factors
(4)
Adult
(3)
Biological And Medical Sciences
(3)
Cardiovascular Diseases - Prevention & Control
(3)
Drug Therapy, Combination
(3)
Medical Sciences
(3)
Obesity
(3)
Prospective Studies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management

High-density lipoprotein, vascular risk, cancer and infection: a case of quantity and quality?

Corrigendum: The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update

Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

Implementation of strategy for the management of overt dyslipidemia: The IMPROVE-dyslipidemia study

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): A prospective-randomized study in middle aged men and women

Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: A systematic review and meta-analysis of randomized-controlled trials

Effect of high and low dose of rosuvastatin on fatty liver disease and adipokines in patients with nonalcoholic fatty liver disease

Cardiovascular benefits of bariatric surgery in morbidly obese patients

Coexistence of cardiovascular risk factors in patients with familial hypercholesterolemia: Data from the HELLAS-FH registry

Clinical characteristics of patients with familial hypercholesterolemia: Data from the HELLAS-FH registry

Latest European guidelines for dyslipidemias in the setting of familial hypercholesterolemia: Data from the hellas-fh registry

Cholesterol levels of high-density lipoprotein (HDL-C), APOB/APOA1 ratio and cardiovascular risk in patients with familial hypercholesterolemia (FH): Data from the HELLAS-FH registry

Vitamin D deficiency, statin-related myopathy and other links with vascular risk

Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease

Inflammatory markers and the metabolic syndrome

Undertreatment of dyslipidaemia in Greece

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A 2 in obese patients with metabolic syndrome

Statin treatment may be beneficial to both the kidneys and the heart

Fenofibrate and Iosartan

The natural history of recently diagnosed autonomic neuropathy over a period of 2 years

EFFECTIVENESS OF EZETIMIBE ALONE OR IN COMBINATION WITH TWICE A WEEK ATORVASTATIN (10 MG) FOR STATIN INTOLERANT HIGH-RISK PATIENTS

PO21-669 STATINS ON RENAL FUNCTION AND SERUM-URIC ACID AND THEIR RELATION TO VASCULAR EVENTS IN CORONARY HEART DISEASE AND METABOLIC SYNDROME

PO20-609 ASSOCIATION OF DRINKING PATTERN WITH THE PREVALENCE OF METABOLIC SYNDROME, DIABETES, CORONARY HEART DISEASE, STROKE AND PERIPHERAL ARTERIAL DISEASE

Suchergebnisse filtern